You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

tumor burden

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Follicular Lymphoma, Tumor Trial in Houston (Obinutuzumab, CC-99282)

Not yet recruiting
  • Follicular Lymphoma
  • Tumor
  • Houston, Texas
    M D Anderson Cancer Center
Oct 30, 2023

Primary Tumor Burden Score:A Novel Staging Parameter for ESCC

Completed
  • Neoplasm, Esophagus
  • Neoplasm, Squamous Cell
  • nCRT
  • (no location specified)
Apr 20, 2023

Mantle Cell Lymphoma, Ketogenic Dieting Trial in New York (Ketogenic Diet)

Recruiting
  • Mantle Cell Lymphoma
  • Ketogenic Dieting
  • Ketogenic Diet
  • New York, New York
    Weill Cornell Medicine
Oct 17, 2022

Cohort Studies Trial in Jinan (apantamide+docetaxel+ADT, apantamide+ADT treatment)

Recruiting
  • Cohort Studies
  • Jinan, Shandong, China
    Qilu hospital
Feb 3, 2023

Follicular Lymphoma Trial (Bendamustine, Rituximab, Tazemetostat)

Not yet recruiting
  • Follicular Lymphoma
  • (no location specified)
Dec 15, 2022

Immunotherapy Among BRAF-Positive Melanoma Patients Treated in

Completed
  • Metastatic Melanoma
  • East Hanover, New Jersey
    Novartis Investigative Site
Nov 11, 2022

Metastatic Hormone-Sensitive Prostate Cancer (mHSPC) Trial in Nanjing (6-month course of antiandrogen drugs, Long-term course of

Recruiting
  • Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)
  • 6-month course of antiandrogen drugs
  • Long-term course of antiandrogen drugs
  • Nanjing, Jiangsu, China
    Urology dpt, First Affiliated Hospital of Nanjing Medical Univer
Jul 13, 2023

Abemaciclib in Combination With Endocrine Therapy as First Line

Recruiting
  • Breast Cancer/ Metastatic Breast Cancer
  • Munich, Germany
    Klinikum rechts der Isar der TU München, Klinik und Poliklinik f
Apr 26, 2022

Circulating Tumor DNA (ctDNA) in Late-stage Breast Cancer

Completed
  • Metastatic Breast Cancer
  • +2 more
  • ctDNA testing
  • (no location specified)
Jun 16, 2022

Neurofibromatosis 1, NF1, Neurofibromatosis Type 1 Trial in Chicago

Recruiting
  • Neurofibromatosis 1
  • +2 more
    • Chicago, Illinois
      Ann & Robert H. Lurie Children's Hospital of Chicago
    Mar 11, 2022

    Cognitive Burden Trial in Chapel Hill (Artificial Intelligence)

    Not yet recruiting
    • Cognitive Burden
    • Artificial Intelligence
    • Chapel Hill, North Carolina
      Lineberger Comprehensive Cancer Center
    Aug 29, 2023

    Diffuse Large B Cell Lymphoma, Follicular Lymphoma Grade 3B Trial in Changchun (R-CDOP)

    Recruiting
    • Diffuse Large B Cell Lymphoma
    • Follicular Lymphoma Grade 3B
    • R-CDOP
    • Changchun, Jilin, China
      The First Bethune Hospital of Jilin University
    Sep 15, 2021

    Cancer, Solid Tumor, Patient Empowerment Trial in Philadelphia (Text triage)

    Completed
    • Cancer
    • +3 more
    • Text triage
    • Philadelphia, Pennsylvania
      Perelman Center for Advanced Care
    Jan 31, 2023

    Neuroendocrine Tumor Trial in Beijing (18F-MFBG)

    Recruiting
    • Neuroendocrine Tumor
    • Beijing, Dongcheng, China
      Peking union medical college hospital
    Sep 25, 2021

    Primary Brain Tumor, Caregiver Burden, Self Care Trial in Kayseri (home care)

    Completed
    • Primary Brain Tumor
    • +2 more
    • home care
    • Kayseri, Eyalet/Yerleşke, Turkey
      Erciyes University Faculty of Health Science
    Apr 7, 2022

    Malignant Glioma, Anxiety, Caregiver Burden Trial in Boston (Psychosocial Intervention Group, Usual Care Group)

    Active, not recruiting
    • Malignant Glioma
    • +3 more
    • Psychosocial Intervention Group
    • Usual Care Group
    • Boston, Massachusetts
      Massachusetts General Hospital Cancer Center
    Jul 12, 2022

    of Radiation Therapy Side Effects in Gastrointestinal Cancers

    Terminated
    Has Results
    • Esophageal Cancer
    • +2 more
    • Specimen collection
    • Bethesda, Maryland
      National Institutes of Health Clinical Center, 9000 Rockville Pi
    Jan 3, 2022

    Lymphoblastic Leukemia, Acute, Childhood Trial in Philadelphia (Tocilizumab, CART 19)

    Completed
    • Lymphoblastic Leukemia, Acute, Childhood
    • Philadelphia, Pennsylvania
      Children's Hospital of Philadelphia
    Jun 30, 2021

    Bladder Cancer, Melanoma Trial in United States (Nivolumab, Nivolumab plus Ipilimumab)

    Active, not recruiting
    • Bladder Cancer
    • Melanoma
    • Farmington, Connecticut
    • +4 more
    May 9, 2022

    Metastatic Breast Cancer Trial in Seoul (Pembrolizumab)

    Not yet recruiting
    • Metastatic Breast Cancer
    • Seoul, Korea, Republic of
      Yonsei Cancer Center at Yonsei University Health System
    Mar 14, 2022

    Refractory or Relapsed Aggressive r/r B-NHL With Huge Tumor Burden Trial in Beijing (Chidamide, Decitabine, Chidamide and

    Unknown status
    • Refractory or Relapsed Aggressive r/r B-NHL With Huge Tumor Burden
    • Beijing, Beijing, China
      Biotherapeutic Department of Chinese PLA General Hospital
    Dec 3, 2020

    Follicular Lymphoma Trial in Germany (Copanlisib, Obinutuzumab)

    Recruiting
    • Follicular Lymphoma
    • München, Bavaria, Germany
    • +39 more
    May 19, 2022

    Disease Burden and Biology Using Tumor Cell Free DNA in

    Recruiting
    • Renal Cell Carcinoma
    • Blood collection
    • Urine collection
    • Nashville, Tennessee
    • +2 more
    Sep 1, 2021

    Indolent Non-Hodgkin Lymphoma Trial in München (Ibrutinib, GA 101)

    Active, not recruiting
    • Indolent Non-Hodgkin Lymphoma
    • München, Bavaria, Germany
      Klinikum der Universität München
    May 6, 2021

    Lenalidomide With Tumor Flare Reaction and High Tumor Burden in

    Recruiting
    • Lymphoma, Mantle-Cell
    • Graz, Austria
    • +86 more
    Oct 19, 2022